References
- Gitlin JD. Wilson disease. Gastroenterology 2003; 125: 1868–77
- Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther 2004; 19: 157–65
- Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997; 113: 212–8
- Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000; 46: 415–9
- Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 2005; 3: 811–88
- Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990; 12: 1234–9
- Sternlieb I. The outlook for the diagnosis of Wilson's disease. J Hepatol 1993; 17: 263–4
- Ferenci P, Caca K, Loudianos G, Mieli–Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23: 139–42
- Dhawan A. Evaluation of the scoring system for the diagnosis of Wilson's disease in children. Liver Int 2005; 25: 680–1
- Tu JB, Blackwell RQ. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967; 16: 507–13
- Kamoun P, Cadoudal M, Rabier D, Jerome H. Detection of Wilson's disease in sibs of a patient with Wilson's disease. Clin Chem 1986; 32: 392
- Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992; 15: 609–15
- Gregorio GV, Mieli-Vergani G, Mowat AP. Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children. J Hepatol 1993; 19: 489
- Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003; 37: 1475–92
- Kingston HM, Jassie LB. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem 1986; 58: 2534–41
- Margarit E, Bach V, Gomez D, Bruguera M, Jara P, Queralt R, et al. Mutation analysis of Wilson disease in the Spanish population: identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet 2005; 68: 61–8
- Motulsky H. Intuitive biostatistics. Oxford University Press, New York 1995; 272–6
- Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002; 6: 15–9
- Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997; 27: 358–62
- LaRusso NF, Summerskill WH, McCall JT. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976; 70: 653–5
- Perman JA, Werlin SL, Grand RJ, Watkins JB. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr 1979; 94: 564–8
- Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981; 21: 169–78
- Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001; 34: 165–71
- Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495–500
- Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061–6
- Gong Y, Frederiksen SL, Gluud C. D-penicillamine for primary biliary cirrhosis. Cochrane Database Syst Rev 2004; 18: CD004789